People in the late stages of cancer and other terminal illnesses are not only unharmed by discontinuing statins for cholesterol management, they may benefit, according to a new study. The research team enrolled 381 patients who faced the likelihood of dying within a year. Among the 192 study patients who continued statins, the median survival was 190 days; the 192 participants who stopped taking the drugs had a median survival of 229 days. Those who discontinued the drugs reported a better overall quality of life, particularly in their psychological well-being.Via ScienceDaily. Posted May 30, 2014.